Systemic Literature Review
Through a comprehensive systematic review of existing literature, Normin Health has thoroughly explored the clinical and health economic value of newly launched drugs and medical devices. Leveraging machine learning methods, Normin Health has established a high-standard literature retrieval process, demonstrating exceptional efficiency and quality in literature searches. In terms of data extraction and integration from the literature, Normin Health has showcased a strong professional background and extensive project experience, ensuring the expertise and precision of data extraction. Moreover, the statistical team of Normin Health employs cutting-edge analytical methods, including network meta-analysis and indirect comparison analysis, to provide advanced statistical insights.
Real-World Studies
Normin Health has extensive experience in extracting, organizing, and analyzing hospital electronic medical records and healthcare insurance data. Through real-world studies, Normin Health evaluates the clinical efficacy and safety of medical products and assesses their impact on healthcare resource utilization and direct medical costs, striving to refine data under the most authentic conditions. Additionally, Normin Health conduct surveys to gather and assess data on patients’ treatment satisfaction, quality of life, and disease progression. To establish a patient-centered real-world database, Normin Health independently developed a patient follow-up management platform app, offering patients real-time services such as diagnosis and treatment records, categorization, tracking, and management.
Health Economics Research
Normin Health has developed a standardized model development and implementation process based on the comprehensive integration of literature evidence and real-world evidence. This process is designed to support market access and includes models such as disease burden models, cost-utility models, and budget impact analysis models. Normin Health possesses the capability to develop models that integrate various dimensions, including patient baseline characteristics, treatment patterns, clinical efficacy, treatment safety, disease natural history, quality of life, and medical costs. Notably, health economic models developed by Normin Health have contributed to listing numerous drugs in the China National Reimbursement Drug List.